[1] |
Zu M, Xu H, Zhang Q, et al. Review of Budd-Chiari syndrome[J]. J Interv Med, 2020, 3(2): 65-76.
|
[2] |
高涌, 余朝文, 陈世远, 等. 皖北地区布加综合征的流行病学及临床特征分析[J]. 中华血管外科杂志, 2016, 1(3): 164-168.
|
[3] |
刘亚, 高涌, 余朝文, 等. 布加综合征患者血清差异蛋白分析[J]. 中华实验外科杂志, 2020, 37(5): 840-842.
|
[4] |
Valla DC. Budd-Chiari syndrome/hepatic venous outflow tract obstruction[J]. Hepatol Int, 2018, 12(Suppl 1): 168-180.
|
[5] |
Qi X, Yang Z, Bai M, et al. Meta-analysis: the significance of screening for JAK2V617F mutation in Budd-Chiari syndrome and portal venous system thrombosis[J]. Aliment Pharmacol Ther, 2011, 33(10): 1087-1103.
|
[6] |
Singh N, Sharma A, Sazawal S, et al. Prevalence of JAK2V617F mutation in deep venous thrombosis patients and its clinical significance as a thrombophilic risk factor: Indian perspective[J]. Clin Appl Thromb Hemost, 2015, 21(6): 579-583.
|
[7] |
刘春江. 皖北地区布加综合征人群分布及JAK2 V617F、exon12基因点突变检测的研究[D]. 蚌埠: 蚌埠医学院, 2015.
|
[8] |
Sniderman AD, Thanassoulis G, Glavinovic T, et al. Apolipoprotein B particles and cardiovascular disease: A narrative review[J]. JAMA Cardiol, 2019, 4(12): 1287-1295.
|
[9] |
Goldštajn MŠ, Toljan K, Grgic F, et al. Sex hormone binding globulin (SHBG) as a marker of clinical disorders[J]. Coll Antropol, 2016, 40(3): 211-218.
|
[10] |
Li Y, Fang L, Yan Y, et al. Association between human SHBG gene polymorphisms and risk of PCOS: A meta-analysis[J]. Reprod Biomed Online, 2021, 42(1): 227-236.
|
[11] |
Shen J, Song J B, Fan J, et al. Distribution and dynamic changes in matrix metalloproteinase (MMP)-2, MMP-9, and collagen in an in stent restenosis process[J]. Eur J Vasc Endovasc Surg, 2021, 61(4): 648-655.
|
[12] |
荣钰. 血清MMP-9,TIMP-1及VEGF水平检测对冠状动脉支架内再狭窄诊断价值的研究[D]. 呼和浩特: 内蒙古医科大学, 2021.
|
[13] |
Ries C. Cytokine functions of TIMP-1[J]. Cell Mol Life Sci, 2014, 71(4): 659-672.
|
[14] |
Vandooren J, Born B, Solomonov I, et al. Circular trimers of gelatinase B/matrix metalloproteinase-9 constitute a distinct population of functional enzyme molecules differentially regulated by tissue inhibitor of metalloproteinases-1[J]. Biochem J, 2015, 465(2): 259-270.
|
[15] |
邸飞, 李洪利, 赵继宗, 等. 基质金属蛋白酶-9及组织基质金属蛋白酶抑制剂-1在脑动静脉畸形组织中的表达及其与出血的关系[J]. 中国卒中杂志, 2009, 4(7): 576-580.
|
[16] |
何霜霜, 吉沥, 孙燕宁. 无水乙醇介入栓塞治疗对脑动静脉畸形患儿神经功能的影响[J]. 河北医学, 2022, 28(1): 102-107.
|
[17] |
刘传玉, 刘程伟, 袁魁, 等. MMP-9、TIMP-1在曲张大隐静脉中的表达及意义[J]. 黑龙江医药科学, 2014, 37(4): 18-19.
|
[18] |
李蕾, 陈黎明, 赵传艳, 等. 血管内皮生长因子对血管内皮细胞ADAMTS5、ADAMTS4及MMP-9表达的影响[J]. 中国老年学杂志, 2013, 33(19): 4759-4761.
|
[19] |
王佾, 张辉, 郭成浩, 等. 下腔静脉隔膜阻塞型布-加综合征的病理学及病因学研究[J]. 介入放射学杂志, 2008, 17(7): 500-503.
|
[20] |
韩新强, 祖茂衡. 血管性血友病因子、内皮素-1和血管内皮生长因子在下腔静脉隔膜型布-加综合征中异常表达的意义[J]. 中华放射学杂志, 2011, 45(6): 580-583.
|
[21] |
Xu M, Cao L, Zhang X, et al. miR-3133 inhibits proliferation and angiogenesis by targeting the JUNB/VEGF pathway in human umbilical vein endothelial cells[J]. Oncol Rep, 2020, 44(4): 1699-1708.
|